ATE480554T1 - Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation - Google Patents

Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation

Info

Publication number
ATE480554T1
ATE480554T1 AT01932626T AT01932626T ATE480554T1 AT E480554 T1 ATE480554 T1 AT E480554T1 AT 01932626 T AT01932626 T AT 01932626T AT 01932626 T AT01932626 T AT 01932626T AT E480554 T1 ATE480554 T1 AT E480554T1
Authority
AT
Austria
Prior art keywords
gene
leukotoxin
protein
necrophorum
sequenced
Prior art date
Application number
AT01932626T
Other languages
English (en)
Inventor
T Nagaraja
George Stewart
Sanjeev Narayanan
M Chengappa
Original Assignee
Univ Kansas State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas State filed Critical Univ Kansas State
Priority claimed from PCT/US2001/013240 external-priority patent/WO2001080886A2/en
Application granted granted Critical
Publication of ATE480554T1 publication Critical patent/ATE480554T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01932626T 2000-04-25 2001-04-25 Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation ATE480554T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55825700A 2000-04-25 2000-04-25
US09/841,786 US6669940B2 (en) 2000-04-25 2001-04-24 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
PCT/US2001/013240 WO2001080886A2 (en) 2000-04-25 2001-04-25 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof

Publications (1)

Publication Number Publication Date
ATE480554T1 true ATE480554T1 (de) 2010-09-15

Family

ID=24228816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01932626T ATE480554T1 (de) 2000-04-25 2001-04-25 Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation

Country Status (4)

Country Link
US (2) US6669940B2 (de)
AT (1) ATE480554T1 (de)
DE (1) DE60143029D1 (de)
ES (1) ES2352322T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669940B2 (en) * 2000-04-25 2003-12-30 Kansas University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
AU2005280147B2 (en) * 2004-08-25 2011-02-24 Epitopix, Llc Fusobacterium polypeptides and methods of use
EP2742875B1 (de) 2007-11-14 2016-02-24 Adhezion Biomedical, LLC Cyanoacrylgewebehaftstoffe
US9308247B2 (en) 2011-03-25 2016-04-12 Kansas State University Research Foundation Compositions and methods for detecting, treating, and protecting against fusobacterium infection
BR112015012288B1 (pt) 2012-11-29 2022-07-26 Cornell University Uso de uma composição veterinária
BR112018009319A8 (pt) 2015-11-09 2019-02-26 Epitopix Llc polipeptídeos de fusobacterium e métodos de uso
BR112022003788A2 (pt) * 2019-08-27 2022-05-24 Relica Genomics Inc Plantas transformadas e métodos para produzir e usar as mesmas
CN110613842B (zh) * 2019-10-15 2022-03-15 黑龙江八一农垦大学 一种牛坏死杆菌的亚单位疫苗及其制备方法
CN111154904A (zh) * 2020-03-02 2020-05-15 黑龙江八一农垦大学 坏死杆菌白细胞毒素基因pcr诊断试剂盒及其建立方法
CN114686445B (zh) * 2022-03-29 2023-07-07 黑龙江八一农垦大学 一种用于检测坏死杆菌白细胞毒素的单克隆抗体、试剂盒及其应用
CN117288947B (zh) * 2023-10-07 2024-09-24 黑龙江八一农垦大学 一种牛坏死杆菌抗体间接elisa检测试剂盒及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203968A (en) 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
US4152415A (en) 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
US4919929A (en) 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
US5455034A (en) 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
AU2001259138B2 (en) * 2000-04-25 2007-06-07 Kansas State University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
US6669940B2 (en) * 2000-04-25 2003-12-30 Kansas University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof

Also Published As

Publication number Publication date
US20090117142A1 (en) 2009-05-07
DE60143029D1 (de) 2010-10-21
US20020054883A1 (en) 2002-05-09
ES2352322T3 (es) 2011-02-17
US6669940B2 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
Schnepf et al. Delineation of a toxin-encoding segment of a Bacillus thuringiensis crystal protein gene.
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
DE60035419D1 (de) Antigene peptide aus neisseria
ATE480554T1 (de) Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
DE68929507D1 (de) Rekombinante mykobakterielle expressions-träger sowie deren verwendung
AR018603A1 (es) Un peptido, util para el tratamiento y/o profilaxis de la enfermedad de alzheimer y el sindrome de down, las composiciones farmaceuticas y vacunas que locontienen, el uso de dicho peptido para la preparacion de las composiciones farmaceuticas, una secuencia de aislado de adn, un plasmido o vector vi
ATE346931T1 (de) Clostridium perfringens impfstoff
ES2236718T3 (es) Proteina portadora de efecto adyuvante, complejo inmunogenico que la contiene, su procedimiento de preparacion, secuencia nucleotidica y vacuna.
BR9306109A (pt) Gene e grupo de genes isolado e purifcado proteína com elevado peso molecular proteína com elevado peso molecular isolada e purificade conjugado e peptideo sintético
Makoff et al. Protective surface antigen P69 of Bordetella pertussis: its characterization and very high level expression in Escherichia coli
DE69839848D1 (de) Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
IL99079A0 (en) Protein structure of the plant toxin gelonin
Futaki et al. Embodying a stable α-helical protein structure through efficient chemical ligation via thioether formation
MY135991A (en) A vaccine-induced hepatits b viral strain and uses thereof
CA2158024A1 (en) A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
WO2005058944A3 (en) Immunogenic peptides fragments of xage-1
ATE474927T1 (de) Schützende hochmolekulargewichtsproteine aus haemophilus influenzae
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
US20090220517A1 (en) Method for producing epitomers and their uses on carrier microorganisms
WO2001074847A3 (en) T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties